Niferex
Payments companies reported to CMS as associated with Niferex. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Niferex, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Niferex
These are the largest totals companies reported as associated with Niferex. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Abbas Motazedi | Washington, DC | Endocrinology, Diabetes & Metabolism | $24.57 |
| Simon Katumu | Tacoma, WA | Family | $22.74 |
| Dhaka Gurung | Roanoke, VA | Family | $21.19 |
| Anis Rehman | Woodbridge, VA | Endocrinology, Diabetes & Metabolism | $21.19 |
| Amanda Bovee | Jefferson, OH | Gerontology (Nurse Practitioner) | $19.22 |
| Yuriy Iskrenko | Meadville, PA | Family Medicine | $19.22 |
| Lindsey Mellott | Austintown, OH | Family Medicine | $19.22 |
| Kurtis Hinderman | Morgan, UT | Family | $18.52 |
| Amanda Moore | Baton Rouge, LA | Family | $14.99 |
| Elizabeth Mouton | Baker, LA | Family | $14.99 |
Prescribed Niferex?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.